Renascience Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 2, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	18,268	23,118	13,322	4,843	5,695	5,669
Market Cap Growth	43.86%	73.53%	175.07%	-14.95%	0.45%	-
Enterprise Value	14,866	20,701	11,479	3,152	3,717	3,323
Last Close Price	1326.00	1678.00	1048.00	381.00	448.00	446.00
PE Ratio	-	-	117.89	-	-	-
PS Ratio	268.65	339.97	100.92	24.97	56.95	40.79
PB Ratio	5.50	6.96	7.75	3.02	3.05	2.58
P/TBV Ratio	5.50	6.96	7.75	3.02	3.05	2.58
EV/Sales Ratio	218.62	304.42	86.96	16.25	37.17	23.91
Debt / Equity Ratio	-	-	-	0.22	0.17	0.09
Net Debt / Equity Ratio	-1.02	-1.02	-1.05	-1.04	-1.02	-0.99
Net Debt / EBITDA Ratio	-	-	10.11	6.65	5.72	10.51
Net Debt / FCF Ratio	11.69	11.69	10.22	7.23	6.65	9.47
Asset Turnover	0.03	0.03	0.07	0.09	0.04	0.08
Quick Ratio	18.96	18.96	12.03	16.11	22.12	64.49
Current Ratio	19.46	19.46	12.39	16.56	22.67	65.62
Return on Equity (ROE)	-11.94%	-11.94%	6.79%	-14.87%	-16.48%	-18.40%
Return on Assets (ROA)	-8.30%	-8.30%	-5.65%	-7.22%	-8.86%	-7.53%
Return on Invested Capital (ROIC)	-	-	-	-	-	-1758.33%
Return on Capital Employed (ROCE)	-10.70%	-10.70%	-10.40%	-12.80%	-15.40%	-8.80%
Earnings Yield	-1.65%	-1.30%	0.85%	-5.33%	-5.88%	-4.48%
FCF Yield	-	-1.26%	-1.32%	-4.77%	-5.02%	-4.07%
Buyback Yield / Dilution	-1.31%	-1.31%	-	-	-11.61%	-15.99%